Tuesday, July 14, 2020

Deep Longevity Snags Series A

San Diego-based Deep Longevity, a new startup using artificial intelligence to focused on aging-related biomarkers, has raised a Series A funding round, the company said on Tuesday. Size of the investment was not announced. According to the company, the funding was led by ETP Ventures and Human Longevity and Performance Impact Venture Fund (HLPIVF)

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.